- Home
- CAAS vs SLGL Comparison
CAAS vs SLGL Comparison
Compare CAAS & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAAS | SLGL |
|---|---|---|
| Founded | N/A | 1997 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.6M | 159.7M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CAAS | SLGL |
|---|---|---|
| Price | $4.16 | $83.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $110.00 |
| AVG Volume (30 Days) | ★ 27.3K | 11.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $122.71 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.50 | $0.40 |
| 52 Week High | $5.37 | $97.97 |
Technical Indicators
Market Signals| Indicator | CAAS | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 39.42 | 57.96 |
| Support Level | $4.13 | $32.56 |
| Resistance Level | $4.40 | $97.97 |
| Average True Range (ATR) | 0.15 | 10.01 |
| MACD | -0.03 | -1.12 |
| Stochastic Oscillator | 25.00 | 56.18 |
Price Performance
Historical ComparisonAbout CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.